Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,300.90 -17.32 -0.11%
S&P 500 1,649.33 -2.48 -0.15%
Nasdaq 3,474.13 -8.05 -0.23%
Ticker Volume Price Price Delta
STOXX 50 2,683.98 -16.95 -0.63%
FTSE 100 6,348.82 -25.39 -0.40%
DAX 8,197.08 -32.43 -0.39%
Ticker Volume Price Price Delta
Nikkei 13,245.20 +237.94 1.83%
Hang Seng 20,986.90 -238.99 -1.13%
S&P/ASX 200 4,861.38 +47.03 0.98%
  • Fund Type: FCP
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

Carnegie Fund - Medical Sub-Fund

+ Add to Watchlist

CARMEII:LX

521.05 NOK 1.72 0.33%

As of 00:59:30 ET on 06/19/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Carnegie Fund - Medical Sub-Fund (CARMEII)

Year To Date: +21.60% 3-Month: +4.52% 3-Year: +13.51% 52-Week Range: 415.29 - 541.42
1-Month: -2.47% 1-Year: +25.90% 5-Year: +8.92% Beta vs LUXXX: 0.55

Mutual Fund Chart for CARMEII

No chart data available.
  • CARMEII:LX 521.05
  • 1M
  • 1Y
Interactive CARMEII Chart

Previous Close

Fund Profile & Information for CARMEII

Carnegie Fund - Medical Sub-Fund is an FCP incorporated in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests globally in equities of companies operating in the pharmaceutical, biotechnology and medical technology sectors.

Inception Date: 12-18-2000 Telephone: 352-40-40-30-1
Managers: ANGELICA FATOUROS
Web Site: www.carnegieam.com

Fundamentals for CARMEII

NAV (on 2013-06-19) 521.05
Assets (M) (on 2013-05-31) 474.45
Fund Leveraged N
Minimum Investment 1,000,000.00
Minimum Subsequent Investment -

Dividends for CARMEII

No dividends reported

Fees & Expenses for CARMEII

Front Load 3.00
Back Load 0.50
Current Mgmt Fee 0.70
Redemption Fee 0.50
12b1 Fee -
Expense Ratio -

Top Fund Holdings for CARMEII

Filing Date: 05/31/2013
Name Position Value % of Total
Pfizer Inc 1,672,359 36,159,462 7.621%
Roche Holding AG 177,900 34,351,919 7.240%
Gilead Sciences Inc 572,832 24,356,289 5.134%
Novartis AG 424,216 23,618,752 4.978%
Celgene Corp 230,387 22,401,153 4.722%
Merck & Co Inc 556,200 20,278,170 4.274%
UnitedHealth Group Inc 369,300 18,375,330 3.873%
Carnegie Fund V - The Carnegie 108,460 17,824,338 3.757%
Fresenius SE & Co KGaA 189,882 17,334,328 3.654%
DaVita HealthCare Partners Inc 139,000 13,453,203 2.836%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil